2021 annual financial data
BriaCell Therapeutics 2021 Operating cash flow margin
BriaCell Therapeutics 2021 operating cash flow margin with verified reported va…
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -8,715,233 USD and net income was -17,267,003 USD.
Operating cash flow was -9,887,579 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,715,233 USD
- Net income
- -17,267,003 USD
- Operating cash flow
- -9,887,579 USD